Skip to main content
. Author manuscript; available in PMC: 2020 Jul 2.
Published in final edited form as: Gene Ther. 2020 Jan 2;27(5):226–236. doi: 10.1038/s41434-019-0120-5

Fig. 6. Tissue GM2 gangliosides reduced 4 months post dosing.

Fig. 6.

GM2 gangliosides in the liver (A), heart (B), spleen (C) and brain (D) were quantified by HPLC-MS/MS. **** p<0.0001 when comparing treated Sandhoff mice to untreated Sandhoff mice.